Utah Medical Products (UTMD) Competitors $52.06 +0.31 (+0.60%) As of 12:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UTMD vs. CERS, OSUR, ANIK, COO, WST, ALGN, MMSI, ICUI, HAE, and XRAYShould you be buying Utah Medical Products stock or one of its competitors? The main competitors of Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Utah Medical Products vs. Cerus OraSure Technologies Anika Therapeutics Cooper Companies West Pharmaceutical Services Align Technology Merit Medical Systems ICU Medical Haemonetics DENTSPLY SIRONA Utah Medical Products (NASDAQ:UTMD) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, community ranking, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment. Does the MarketBeat Community favor UTMD or CERS? Cerus received 416 more outperform votes than Utah Medical Products when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 61.60% of users gave Utah Medical Products an outperform vote. CompanyUnderperformOutperformUtah Medical ProductsOutperform Votes15461.60% Underperform Votes9638.40% CerusOutperform Votes57072.34% Underperform Votes21827.66% Which has more volatility & risk, UTMD or CERS? Utah Medical Products has a beta of 0.17, indicating that its stock price is 83% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.7, indicating that its stock price is 70% more volatile than the S&P 500. Which has preferable earnings & valuation, UTMD or CERS? Utah Medical Products has higher earnings, but lower revenue than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUtah Medical Products$40.90M4.18$13.87M$3.9513.18Cerus$180.27M1.38-$37.49M-$0.11-11.86 Does the media prefer UTMD or CERS? In the previous week, Cerus had 3 more articles in the media than Utah Medical Products. MarketBeat recorded 6 mentions for Cerus and 3 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 0.92 beat Cerus' score of 0.37 indicating that Utah Medical Products is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Utah Medical Products 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cerus 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is UTMD or CERS more profitable? Utah Medical Products has a net margin of 33.92% compared to Cerus' net margin of -11.60%. Utah Medical Products' return on equity of 11.07% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Utah Medical Products33.92% 11.07% 10.53% Cerus -11.60%-40.55%-11.12% Do insiders and institutionals have more ownership in UTMD or CERS? 69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 78.4% of Cerus shares are owned by institutional investors. 7.4% of Utah Medical Products shares are owned by insiders. Comparatively, 3.4% of Cerus shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts recommend UTMD or CERS? Cerus has a consensus target price of $3.50, indicating a potential upside of 168.20%. Given Cerus' stronger consensus rating and higher probable upside, analysts plainly believe Cerus is more favorable than Utah Medical Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryUtah Medical Products and Cerus tied by winning 9 of the 18 factors compared between the two stocks. Get Utah Medical Products News Delivered to You Automatically Sign up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTMD vs. The Competition Export to ExcelMetricUtah Medical ProductsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$170.85M$4.35B$5.49B$7.97BDividend Yield2.33%39.94%5.11%4.23%P/E Ratio13.1830.6422.6118.58Price / Sales4.1855.26397.51103.15Price / Cash9.5951.0838.1834.62Price / Book1.476.046.704.26Net Income$13.87M$68.71M$3.22B$248.31M7 Day Performance-1.53%-0.85%1.26%1.34%1 Month Performance-7.04%-2.95%3.73%3.92%1 Year Performance-23.29%22.54%15.82%5.33% Utah Medical Products Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTMDUtah Medical Products2.3526 of 5 stars$52.06+0.6%N/A-21.8%$170.85M$40.90M13.18180Earnings ReportNews CoverageCERSCerus2.0439 of 5 stars$1.29-0.8%$3.50+171.3%-21.0%$239.67M$180.27M-11.73290News CoverageOSUROraSure Technologies4.5644 of 5 stars$2.87-4.0%$5.50+91.6%-43.5%$214.68M$185.83M19.13840Upcoming EarningsANIKAnika Therapeutics4.0625 of 5 stars$14.03+0.1%$21.67+54.4%-43.9%$198.89M$119.91M-2.11300COOCooper Companies3.3189 of 5 stars$78.70-1.0%$110.25+40.1%-8.3%$15.74B$3.93B40.3614,000Positive NewsWSTWest Pharmaceutical Services4.6396 of 5 stars$206.02+2.0%$332.50+61.4%-40.9%$14.89B$2.89B30.8010,700Earnings ReportDividend AnnouncementAnalyst RevisionALGNAlign Technology4.3529 of 5 stars$172.22+0.5%$256.90+49.2%-38.6%$12.61B$4.00B30.7023,200Earnings ReportAnalyst ForecastNews CoverageGap UpMMSIMerit Medical Systems3.9705 of 5 stars$89.60-1.4%$114.33+27.6%+27.5%$5.29B$1.36B43.926,850Earnings ReportShort Interest ↑Analyst RevisionICUIICU Medical3.8714 of 5 stars$136.72-1.4%$162.67+19.0%+39.5%$3.35B$2.38B-29.9214,500Upcoming EarningsNews CoveragePositive NewsHAEHaemonetics4.6258 of 5 stars$57.03-0.2%$101.22+77.5%-31.5%$2.87B$1.37B22.452,820Upcoming EarningsNews CoveragePositive NewsXRAYDENTSPLY SIRONA4.8966 of 5 stars$12.82-0.1%$22.58+76.2%-53.7%$2.55B$3.79B-6.1915,000Upcoming EarningsAnalyst ForecastPositive News Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives Cooper Companies Alternatives West Pharmaceutical Services Alternatives Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives Haemonetics Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UTMD) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Utah Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Utah Medical Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UTMD Stock Free UTMD Stock Alerts